# TAGAMET HB 200
> **NDA020951** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1999-07-09
## Drug
- **FDA Application Number:** NDA020951
- **Application type:** New Drug Application
- **Brand name:** TAGAMET HB 200
- **Generic name:** Cimetidine
- **Active ingredients:** CIMETIDINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GLAXOSMITHKLINE
- **First approval:** 1999-07-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020951)
---
*MORVS · CC0 1.0*